Company Overview 

News & Media

Join Our Team

News & Events

Our resource center provides company news, thought leadership content, and upcoming virtual events.

Posts about

Biologics

Parenteral Market Trends

With today’s growing pipeline of biologics, namely complex oncology products often delivered...

Alcami Adds Additional Formulation Development Capabilities

Formulation Development Suite to Support Small and Large Molecule Programs

Morrisville, North...

Alcami Expands Biologics Footprint with Investment in Durham

$10 Million Investment Doubles Laboratory Footprint & Enhances Large Molecule and Cell & Gene...

Bioanalytical Testing Trends in 2022

An increasing number of clinical trial registrations, more R&D investment, growing demand for...

Alcami to Provide Analytical Support Services for Novavax’ COVID-19 Vaccine Candidate

DURHAM, N.C. – November 16, 2021 – Alcami, a leading United States-based contract development and...

Outsourcing Trends in the Development of Biologics

The development of biologic drugs continues to increase at a rapid pace. Growing numbers of...

Fill-Finish Development Challenges & Solutions for CDMOs

Recently, contract development and manufacturing organizations (CDMOs) involved in the...

White Paper: Host Cell Impurities, Bioassays, Micro-Flow Imaging

As opposed to traditional drug production, the production of biological products (biologics)...

EDITORIAL: Combination Products and their Regulatory Pathway

Combination products are becoming increasingly important to pharmaceutical CDMOs like Alcami, said...

On-Demand Lab Open House

From standalone projects through full-service programs, our laboratories provide solutions to your...

ON-DEMAND WEBINAR: Extractables & Leachables

Requirements from regulatory agencies have become increasingly rigorous with regards to the...

Part Two: Cell-Based Bioassays

Part Two: Cell-Based Bioassays

Part One: Biologics and the Problem with Residual DNA

Part One: Biologics and the Problem with Residual DNA